Tag Archives: dyslipidaemia
July 2006 Br J Cardiol 2006;13:273-7
Safety and tolerability of prolonged-release nicotinic acid combined with a statin in NAUTILUS
Anja Vogt, Ursula Kassner, Ulrike Hostalek, Elisabeth Steinhagen-Thiessen, on behalf of the NAUTILUS Study Group
No content available
July 2006 Br J Cardiol 2006;13:278-82
Safety and tolerability of prolonged-release nicotinic acid in patients aged > 65 years enrolled in NAUTILUS
Anja Vogt, Ursula Kassner, Ulrike Hostalek, Elisabeth Steinhagen-Thiessen, on behalf of the NAUTILUS Study Group
No content available
May 2006 Br J Cardiol 2006;13:205-208
Do fibrates offer special benefits in treating diabetic dyslipidaemia? Lessons from FIELD
Hugh F McIntyre
No content available
March 2005 Br J Cardiol 2005;12:118-22
Dyslipidaemia in ethnic populations: special considerations
Anthony H Barnett
No content available
March 2004 Br J Cardiol 2004;11:129-36
Evolution of the HMG CoA reductase inhibitors (statins) in cardiovascular medicine
Christopher J Packard
No content available
November 2003 Br J Cardiol 2003;10:462-8
Modified-release nicotinic acid for dyslipidaemia: novel formulation improves tolerability and optimises efficacy
Michael Schachter
No content available
For healthcare professionals only
